16.49
0.55%
+0.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Catalyst Pharmaceuticals Inc Azioni (CPRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
7.67%
110.57
|
102.69 | 99.58 | 85.37 | 60.76 |
Cost Of Revenue |
11.59%
15.81
|
14.17 | 12.04 | 9.946 | 11.20 |
Gross Profit |
7.05%
94.76
|
88.52 | 87.54 | 75.42 | 49.56 |
Operating Expenses
|
57.79%
53.07
|
125.71 | 40.84 | 39.81 | 18.76 |
Benefits Costs and Expenses |
54.61%
63.86
|
140.71 | 51.07 | 48.05 | 27.75 |
Costs And Expenses |
54.61%
63.86
|
140.71 | 51.07 | 48.05 | 27.75 |
Operating Income/Loss |
212.11%
41.69
|
-37.19 | 46.70 | 35.61 | 30.80 |
Income/Loss From Continuing Operations Before Tax |
222.85%
46.71
|
-38.02 | 48.51 | 37.31 | 33.01 |
Income Tax Expense/Benefit |
263.47%
11.86
|
-7.257 | 10.75 | 7.745 | 7.537 |
Income/Loss From Continuing Operations After Tax |
213.26%
34.84
|
-30.76 | 37.76 | 29.57 | 25.47 |
Net Income/Loss
|
213.26%
34.84
|
-30.76 | 37.76 | 29.57 | 25.47 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.86%
0.1467
|
106.57 | 106.26 | 105.56 | 0.4073 |
Diluted Average Shares |
100.00%
0.00178
|
106.57 | 113.67 | 113.99 | 1.0234 |
Basic Earnings Per Share |
213.79%
0.33
|
-0.29 | 0.36 | 0.28 | 0.24 |
Diluted Earnings Per Share |
206.90%
0.31
|
-0.29 | 0.33 | 0.26 | 0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):